High drug prices in the United States are a sorely contested topic between consumers, lawmakers, and officials at pharmaceutical companies. The political pressure to lower drug prices is high and drug prices remain pharma’s biggest business and reputational risk.1 On Tuesday, February 26, 2019, officials from seven of the largest drug makers in the United…
Author: Melissa Santos
Potential Consequences of Lowering Current Medicare Drug Prices
On October 25, 2018, President Trump unveiled a new plan that would completely change how Medicare pays for certain pricey drugs.1 It is an unorthodox move for Republicans, but Trump is pushing ahead with his bold plan to lower drug prices.2 As one of the promises of his presidency, Trump has set out to lower…